BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elzinga S, Murdock BJ, Guo K, Hayes JM, Tabbey MA, Hur J, Feldman EL. Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? Exp Neurol 2019;320:112967. [PMID: 31145897 DOI: 10.1016/j.expneurol.2019.112967] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Deravi N, Poudineh M, Pirzadeh M, Yavarpour-bali H, Mehrabi H, Erabi G, Saghazadeh A, Rezaei N. The Yin and Yang of toll-like receptors in endothelial dysfunction. International Immunopharmacology 2022;108:108768. [DOI: 10.1016/j.intimp.2022.108768] [Reference Citation Analysis]
2 Savelieff MG, Feldman EL. Immune-mediated vincristine-induced neuropathy: Unlocking therapies. J Exp Med 2021;218:e20210286. [PMID: 33751022 DOI: 10.1084/jem.20210286] [Reference Citation Analysis]
3 Fujita Y, Murakami T, Nakamura A. Recent Advances in Biomarkers and Regenerative Medicine for Diabetic Neuropathy. Int J Mol Sci 2021;22:2301. [PMID: 33669048 DOI: 10.3390/ijms22052301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jacob L, Koyanagi A, Smith L, Tanislav C, Konrad M, van der Beck S, Kostev K. Prevalence of, and factors associated with, long-term COVID-19 sick leave in working-age patients followed in general practices in Germany. Int J Infect Dis 2021;109:203-8. [PMID: 34224870 DOI: 10.1016/j.ijid.2021.06.063] [Reference Citation Analysis]
5 Busa P, Kuthati Y, Huang N, Wong C. New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors. Front Pharmacol 2022;13:864088. [DOI: 10.3389/fphar.2022.864088] [Reference Citation Analysis]
6 Yehualashet AS. Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications. Diabetes Metab Syndr Obes. 2020;13:4763-4777. [PMID: 33311992 DOI: 10.2147/dmso.s274844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhao B, Zhang Q, Liang X, Xie J, Sun Q. Quercetin reduces inflammation in a rat model of diabetic peripheral neuropathy by regulating the TLR4/MyD88/NF-κB signalling pathway. Eur J Pharmacol 2021;912:174607. [PMID: 34743981 DOI: 10.1016/j.ejphar.2021.174607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Stino AM, Rumora AE, Kim B, Feldman EL. Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy. J Peripher Nerv Syst. 2020;25:76-84. [PMID: 32412144 DOI: 10.1111/jns.12387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
9 Xie M, Wu D, Li G, Yang J, Zhang YS. Exosomes targeted towards applications in regenerative medicine. Nano Select 2021;2:880-908. [DOI: 10.1002/nano.202000251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
10 Łukawska-tatarczuk M, Mrozikiewicz-rakowska B, Franek E, Czupryniak L. Rola autoimmunizacji w rozwoju powikłań cukrzycowych – przegląd badań. Postępy Higieny i Medycyny Doświadczalnej 2021;75:802-14. [DOI: 10.2478/ahem-2021-0043] [Reference Citation Analysis]
11 Aghamiri SH, Komlakh K, Ghaffari M. The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy. Inflammopharmacology 2022. [PMID: 35020096 DOI: 10.1007/s10787-021-00919-3] [Reference Citation Analysis]
12 Aghamiri SH, Komlakh K, Ghaffari M. Toll-Like Receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy. Int Immunopharmacol 2022;102:108398. [PMID: 34863652 DOI: 10.1016/j.intimp.2021.108398] [Reference Citation Analysis]
13 Kudoh K, Mizukami H, Itabashi C, Fuke N, Osonoi S, Takeuchi Y, Wada K, Igawa A, Ogasawara S, Ishibashi Y, Hakamada K, Yagihashi S, Nakaji S. Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population. BMJ Open Diabetes Res Care 2020;8:e001739. [PMID: 33099510 DOI: 10.1136/bmjdrc-2020-001739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Guo K, Eid SA, Elzinga SE, Pacut C, Feldman EL, Hur J. Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy. Clin Epigenetics 2020;12:123. [PMID: 32787975 DOI: 10.1186/s13148-020-00913-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
15 Fan B, Li C, Szalad A, Wang L, Pan W, Zhang R, Chopp M, Zhang ZG, Liu XS. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63:431-443. [PMID: 31740984 DOI: 10.1007/s00125-019-05043-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]